Both in Biotechnology
ImageneBio vs Kalaris Therapeutics
Over the past year IMA returned −52.3% and KLRS returned −57.9%; their daily moves had a correlation of 0.10.
IMA −52.3% KLRS −57.9%Growth of $1, one year, split-adjusted
| Metric | IMA | KLRS |
|---|---|---|
| Price | $4.02 | $2.05 |
| Market cap | $45.6M | $48.8M |
| Today | −1.71% | +2.50% |
| 1 month | −14.5% | −27.6% |
| 6 months | −31.0% | −61.3% |
| Year to date | −41.7% | −75.7% |
| 1 year | −53.8% | −59.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $136.2M | $93.5M |
| Dividend yield | — | — |
| Volatility (60d) | 37.3% | 56.1% |
| Short % of float | 0.6% | 5.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).